Tag: Vascular access

Vascular Therapies announces clinical results from phase 3 randomised multicentre clinical...

Vascular Therapies recently announced results from its phase 3 clinical trial in which Sirogen showed encouraging arteriovenous fistula (AVF) outcomes in elderly end-stage renal...
acute

New standardised reporting system suggests arteriovenous graft infections may be less...

“Using an objective system that discriminates between aetiology and outcome allows a more complete, objective understanding of relative infection risks and outcomes for arteriovenous...

LINC 2021 first time data releases in arteriovenous access: Positive results...

New data presented for the first time at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) are positive for the IN.PACT AV drug-coated...
Artio Medical

Artio Medical announces successful first human use of the Amplifi vein...

Artio Medical recently announced that it has successfully completed the first human use of its Amplifi vein dilation system. The first clinical procedure was...
Avenu Ellipsys

Largest US nephrology group is first in Illinois to offer Ellipsys...

Nephrology Associates of Northern Illinois and Indiana (NANI), the largest nephrology group in the USA, is the first practice in Illinois to adopt the Ellipsys vascular access system (Avenu Medical, now...

Network meta-analysis finds DCB angioplasty “significantly superior” to plain balloon angioplasty...

A recent network meta-analysis shows that, in failing arteriovenous fistulas (AVFs) with outflow stenosis, drug-coated balloon (DCB) angioplasty is “significantly superior” to plain balloon...

COVID-related hypercoagulability linked to elevated malfunction rate in temporary haemodialysis catheters

Hypercoagulability in COVID-19 patients leads to an increase in the malfunction rate of temporary haemodialysis catheters—but heparin locking of the catheters is linked to...

Risk of ischaemic steal syndrome and patency rate comparable for tapered...

In their recent systematic review and meta-analysis, Venkata Sai Jasty (University of Arizona, Tuscon, USA) and colleagues found that the risk of ischaemic steal...
femoral

New protocol helps identify best venipuncture site for femoral access

RaFeVA (Rapid Femoral Vein Assessment), a new protocol, is a rapid and effective tool for the systematic ultrasound evaluation of the veins in the...
patency

Older age and diabetes mellitus identified as risk factors for poor...

Different risk factors affect patency between vascular access construction and the first percutaneous transluminal angioplasty, Mahoko Yoshida (Hiroshima University Hospital, Hiroshima, Japan) and colleagues...

Clinician survey reveals significant variation in ultrasound-guided PIV insertion

A new survey among vascular access (VA) and emergency department (ED) clinicians has revealed significant levels of variation in ultrasound-guided peripheral IV (UGPIV) practices...

Teleflex announces expanded indications for the Arrow EZ-IO intraosseous vascular access...

Teleflex has announced it has received 510(k) clearance from the US Food and Drug Administration to expand the indications for use of the Arrow...

Dialysis access needs to be a priority in the COVID-19 era

Panagiotis M Kitrou and Nicholas Inston discuss the impact of the COVID-19 pandemic on vascular access services. Despite the disruption caused, they are optimistic...

Patient-specific computation model may improve AVF maturation rates

The results of a randomised controlled trial—the Shunt simulation study—show that a new patient-specific computation model accurately calculated postoperative access flow. As flow is...

New study shows advantages of Ellipsys system in creating reliable dialysis...

A new study shows significant benefits of the Ellipsys vascular access system (Avenu Medical) in easily and safely creating durable vascular access for end-stage...

CX 2020 LIVE: Vascular Access session showcases new technologies, while debate...

The CX 2020 LIVE Vascular Access Consensus session sparked global interest, with chair Nick Inston (Birmingham, UK) and moderator Domenico Valenti (London, UK) taking...
VasQ external support

Published real-world experience demonstrates VasQ External Support improves outcomes when adopted...

Robert Shahverdyan, head of the Vascular Access Center at Asklepios Klinik Barmbek, Hamburg, Germany, has recently published a retrospective analysis of his first 32...

IVUS during haemodialysis access “aids device selection and adequacy of treatment”

Narayan Karunanithy outlines the benefits of intravascular ultrasound (IVUS) during haemodialysis access intervention. Thoracic central veins include intra-thoracic segments of the internal jugular, subclavian, brachiocephalic...
covera

A thumbnail sketch of haemodialysis access: Past, present, and future in...

Bart Dolmatch gives an overview of the history of haemodialysis access in the USA, and balances the pros and cons of current access options....
overhead

Adept Medical launches the Antegrade IR platform

Adept Medical has launches its Antegrade IR platform, which provides a work surface for antegrade femoral approach during interventional radiology vascular procedures. The device...
hybrid

No significant differences between hybrid and open approaches for managing thrombosed...

Data from the University of Pittsburgh Medical Center (Pittsburgh, USA) indicate that the open approach to managing thrombosed haemodialysis grafts with venous anastomotic lesions...
vascular access

“More creative solutions” needed for end-stage vascular access patients

Nicholas (Nick) Inston calls for “more creative solutions” to vascular access challenges, commending interventional radiologists’ innovative reputation as instrumental to increasing the number of...
Resolve

Merit Medical launches new PreludeSYNC EVO radial compression device

Merit Medical have announced the commercial launch of the PreludeSYNC EVO radial compression device in the USA. The PreludeSYNC EVO is a sterile, single-use,...
SAVE-US

SAVE-US pivotal trial completes enrollment and has positive clinical results

The SAVE-US (Surfacer system to facilitate access in venous occlusions—United States) pivotal trial has completed enrollment. The SAVE-US trial is evaluating the safety and...

Comparing and contrasting surgically-created AVFs with those made by endovascular means

 Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and...

AngioDynamics provides update on vascular access business

AngioDynamics has provided a corporate update and acknowledged a recent, favourable US District Court ruling that impacts its vascular access business. A press release states...

EchoNous Vein receives FDA approval

EchoNous Vein (EchoNous), an ultrasound-based tool designed specifically for nurses to improve peripheral IV catheter placements, has received US Food and Drug Administration (FDA)...

BD acquires TVA Medical, makers of everlinQ endoAVF System

BD (Becton, Dickinson and Company) announced it has completed the acquisition of TVA Medical, a company that develops minimally invasive vascular access solutions...

FDA approves Ellipsys Vascular Access System for non-surgical dialysis fistula creation

Ellipsys Vascular Access System (Avenu Medical) has been granted De Novo marketing authorisation from the Food and Drug Administration (FDA). Ellipsys is a minimally-invasive...

Humacyte appoints Jeffrey Lawson as president and CEO

Humacyte, an innovator in biotechnology and regenerative medicine, has announced that Jeffrey Lawson has been appointed president and chief executive officer. The former chairman...